Journal of Cataract & Refractive Surgery
Volume 36, Issue 9 , Pages 1494-1498 , September 2010

Outcomes of cataract surgery and intraocular lens implantation with and without intracameral triamcinolone in pediatric eyes

Received 17 November 2009 ,Revised 26 February 2010 ,Accepted 2 March 2010.

References 

  1. Wadood AC, Armbrecht AM, Aspinall PA, Dhillon B. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification. J Cataract Refract Surg. 2004;30:761–768
  2. Laurell C-G, Zetterström C. Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. Br J Ophthalmol. 2002;86:1380–1384Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1771439/pdf/bjo08601380.pdfAccessed May 11, 2010
  3. Tan DTH, Chee S-P, Lim L, Lim ASM. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology. 1999;106:223–231
  4. Negi AK, Browning AC, Vernon SA. Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery; randomized controlled trial. J Cataract Refract Surg. 2006;32:468–474
  5. Shah SK, Vasavada V, Praveen MR, Vasavada AR, Trivedi RH, Dixit NV. Triamcinolone-assisted vitrectomy in pediatric cataract surgery. J Cataract Refract Surg. 2009;35:230–232
  6. Praveen MR, Shah SK, Vasavada VA, Dixit NV, Vasavada AR, Garg VS, Trivedi RH. Triamcinolone-assisted vitrectomy in pediatric cataract surgery: intraoperative effectiveness and postoperative outcome. In press, J AAPOS 2010
  7. Dholakia SA, Praveen MR, Vasavada AR, Nihalani B. Completion rate of primary posterior continuous curvilinear capsulorhexis and vitreous disturbance during congenital cataract surgery. J AAPOS. 2006;10:351–356
  8. Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol. 2002;240:423–429
  9. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina. 2000;20:554–555
  10. Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 1986;101:190–195
  11. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol. 2001;29:2–6
  12. Yamakiri K, Uchino E, Kimura K, Sakamoto T. Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery. Am J Ophthalmol. 2004;138:650–652
  13. Burk SE, Da Mata AP, Snyder ME, Schneider S, Osher RH, Cionni RJ. Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg. 2003;29:645–651
  14. Kaynak S, Celik L, Kocak N, Oner FH, Kaynak T, Cingil G. Staining of vitreous with triamcinolone acetonide in retained lens surgery with phacofragmentation. J Cataract Refract Surg. 2006;32:56–59
  15. Trivedi RH, Wilson ME, Bartholomow LR, Lal G, Peterseim MM. Opacification of the visual axis after cataract surgery and single acrylic intraocular lens implantation in the first year of life. J AAPOS. 2004;8:156–164
  16. Li J, Heinz C, Zurek-Imhoff B, Heiligenhaus A. Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis. J Cataract Refract Surg. 2006;32:1535–1539
  17. Dada T, Dhawan M, Garg S, Nair S, Mandal S. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. J Cataract Refract Surg. 2007;33:1613–1618
  18. Chang C-J, Chiang S-Y, Chen C-L, Wang T-Y. Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification. J Cataract Refract Surg. 2006;32:2054–2059
  19. Jonas JB, Kreissig I, Degenring RF. Endophthalmitis after intravitreal injection of triamcinolone [letter]. Arch Ophthalmol. 2003;121:1663–1664
  20. Nelson ML, Tennant MTS, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003;23:686–691
  21. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003;136:791–796
  22. Sakamoto T, Enaida H, Kubota T, Nakahara M, Yamakiri K, Yamashita T, et al. Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. Am J Ophthalmol. 2004;38:137–138
  23. Tan DTH, Chee S-P, Lim L, Theng J, Van Ede M. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery; anterior versus posterior placement of two Surodex in the eye. Ophthalmology. 2001;108:2172–2181
  24. Espiritu CRG, Caparas VL, Bolinao JG. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg. 2007;33:63–68

 Supported in part by National Institutes of Health grant EY-14793 (Dr. Trivedi) and an unrestricted grant to MUSC-SEI from Research to Prevent Blindness, Inc., New York, New York, USA.

PII: S0886-3350(10)00834-5

doi: 10.1016/j.jcrs.2010.03.040

Journal of Cataract & Refractive Surgery
Volume 36, Issue 9 , Pages 1494-1498 , September 2010

Article Tools